Biocare Medical LLC
Pacheco, CA
- UEI
- MS7LZ6JPYNQ5
- CAGE
- 1U5G0
- Primary NAICS
- 325413 In-Vitro Diagnostic Substance Manufacturing
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 60 Berry Dr, Pacheco, CA 94553, USA
- Website
- biocare.net
- Founded
- 1997
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $128,308 |
| FY2025 | $128,756 |
| FY2024 | $406,501 |
| FY2023 | $81,583 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Defense Health Agency | $86,438 | |
| 2 | Department of Health and Human Services | $27,875 | |
| 3 | Department of Agriculture | $13,995 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Cancer Diagnostics, Inc. | Durham, NC | 325413 In-Vitro Diagnostic Substance Manufacturing |
| Agilent Technologies Inc. | Carpinteria, CA | 334516 Analytical Laboratory Instrument Manufacturing |
| Sakura Finetek U.s.a., Inc. | Torrance, CA | 423450 Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers |
| San Diego Pathology | San Diego, CA | 621511 Medical Laboratories |
| Cell Marque Corp | — | 325413 In-Vitro Diagnostic Substance Manufacturing |
About the company
Biocare Medical LLC, a for-profit limited liability company based in Pacheco, California, manufactures immunohistochemistry (IHC) products and automated medical staining systems sold to federal agencies as a prime contractor on full-and-open purchase orders with no set-aside designations. The vendor competes exclusively outside set-aside categories across its 449 federal awards spanning the past two decades.
Biocare's federal capability footprint centers on three concrete product lines: automated slide staining systems (IntelliPath+, IntelliPath FLX, ONCORE PROX) and preventive maintenance agreements; immunohistochemistry reagents, antibodies, and consumables; and diagnostic equipment repair and service. Recent representative awards include a $147,975 firm-fixed-price purchase order from the Office of Administrative Services Procurement Management Branch (September 2024) for an IntelliPath+ automated slide staining system and preventive maintenance agreement with performance in Athens, Georgia, running through September 2029; a $225,275 purchase order from the Defense Health Agency (March 2024) for medical antibodies for laboratory use with performance in Bethesda, Maryland through March 2027; a $144,000 purchase order from the National Institute on Aging (May 2024) for an ONCORE PROX automated slide staining system; a $133,043 purchase order from the Food and Drug Administration (June 2024) under a Total Small Business set-aside for an IHC autostainer; and a $72,500 purchase order from the National Institute of Mental Health (August 2026) for maintenance services at its Bethesda facility running through July 2031.
Customer concentration spreads across federal health and defense agencies. The Defense Health Agency dominates by potential value with 9 awards worth $7 million combined, followed by the Department of the Army Medical Command (6 awards, $1.9 million), Department of Veterans Affairs VISNs 6 and 2 (16 awards each, $1.9 million and $810 thousand respectively), and the Centers for Disease Control and Prevention Pittsburgh (14 awards, $493 thousand). These five customers anchor 75% of combined potential value while representing only 16% of award count, indicating large-dollar single orders concentrated in defense and VA health systems. Across all 449 awards, Biocare serves 31 distinct federal agencies.
Biocare places task orders under GSA Federal Supply Schedules GS07F0029U and GS07F0030U (15 and 7 task orders respectively), a Department of the Army Medical Command blanket purchase agreement valued at $187,800 (5 task orders), and two IDIQs carrying additional volume. The vendor's activity has contracted sharply — from a historical baseline of consistent annual awards through 2020, volume dropped to three awards in 2022, two in 2023, five in 2024, and one each in 2025 and 2026. Only two awards totaling $280 thousand complete within the next twenty-four months, indicating limited near-term recompete exposure. The combined potential value across all 449 awards is $16.1 million, with $5.8 million obligated to date (36% realization rate), reflecting the typical slow burn of equipment maintenance and supply-on-demand purchase orders spanning five to seven years each.
SBA capabilities narrative
histology related reagents, antibodies, detection systems, buffers, solutions,and other related products used by diagnostic and research centers for the diagnosis of cancer and other infectious diseases
Quick answers
Is Biocare Medical LLC registered in SAM.gov?
Yes. Biocare Medical LLC's SAM.gov registration is active through March 17, 2027.
How much has Biocare Medical LLC received in federal contracts?
Federal contracts obligated $128,756 to Biocare Medical LLC in fiscal year 2025 and $745,149 in fiscal years 2023 through 2027.
How does Biocare Medical LLC rank among federal contractors?
Biocare Medical LLC ranked #100 in NAICS 325413 in FY2025.
What is Biocare Medical LLC's most recent federal award?
Biocare Medical LLC's most recent federal contract award is Maintenance services (75N98026P00762), from Assistant Secretary for Financial Resources, on August 1, 2026.
On GovTribe
See Biocare Medical LLC's full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors